Microba secures $3.06M R&D tax refund, boosting cash position to support gastrointestinal diagnostics and clinical therapeutics development @MicrobaLife $MAP
https://t.co/DT7Agllbrn
Phoslock Environmental Technologies resumes production at its China facility in January 2026 after four years, driven by depleted inventory @PhoslockWater $PET
https://t.co/9AnefSBhB4
Immuron secures US Department of Defense sub-award to develop oral therapeutics targeting military diarrhoea threats. @immuronltd $IMC
https://t.co/4qSywqrO0b
@MicroequitiesAM delivers $1.9M November profit as Pure Microcap Value Fund drives strong performance, pushing 1H26 YTD to $5.3M. $MAM
https://t.co/mZlSf5fmaQ
Kelly Partners climbs to 17th in AFR Top 100 Accounting Firms with $164.2M revenue run rate, now 82% of the way to cracking Top 10. $KPG
https://t.co/hT0RgX3rSP
Avecho Biotechnology secures US and European patent allowances for its CBD TPM® soft-gel capsule, protecting the formulation until 2040. $AVE
https://t.co/RHWV5Z1BT8
4DMedical secures major distribution partnership with Philips, guaranteeing A$15M minimum revenue across 2026-2027 for FDA-cleared CT:VQ™ technology. $4DX
https://t.co/lcj1ks4IsO
OncoSil's OSPREY registry shows 20.6-22.0 month survival in pancreatic cancer patients vs 12.7-18.8 months for chemotherapy alone. $OSL
https://t.co/fBrA6GiKvP
Microba scores $3.06M R&D tax refund, boosting cash to ~$17M and extending runway for GI diagnostics and therapeutics without diluting shareholders @MicrobaLife $MAP
https://t.co/CbNBxrDYMY
Invion secures perpetual global rights to Photosoft™ technology across $96.4B cancer markets via milestone-based share issuance. @InvionLimited $IVX
https://t.co/IpnvmGALba
Phoslock Environmental Technologies restarts manufacturing at its China facility in January 2026, with initial capacity of 3,000 tonnes annually. @PhoslockEnviro $PET
https://t.co/IkSU2MhAPw
Island Pharmaceuticals secures $1M from insiders including Chairman Jason Carroll for Galidesivir antiviral programme, boosting cash to $7.91M. $ILA
https://t.co/jkZq0l5N1K
BetMakers renews Penn Entertainment contract for 3 years with improved terms, boosting EBITDA by A$1.2M annually while adding 16 new Apollo customers. $BET
https://t.co/atv4UbXiLR
Li-S Energy partners with UK defence contractor @MSubsLtd to test lithium-sulfur batteries for autonomous submarines, targeting Royal Navy programmes. $LIS
https://t.co/sbh1XE7MQN
Amplia Therapeutics secures US patent grant for cancer drug narmafotinib, protecting its formulation until 2040 across major markets. $ATX
https://t.co/7iT118CnXo
Optiscan Imaging launches pivotal head and neck cancer study at Perth hospital, with data set to support FDA submissions @OptiscanImaging $OIL
https://t.co/hhbT4wkrUi
BCAL Diagnostics secures national ethics approval for landmark BREASTEST Registry, enrolling up to 24,000 women @BCALDxLtd $BDX
https://t.co/NfSbUOMEXs